Detalhe da pesquisa
1.
Guiding principles on the education and practice of theranostics.
Eur J Nucl Med Mol Imaging
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453729
2.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging
; 50(3): 892-907, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334104
3.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 50(9): 2830-2845, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246997
4.
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
J Neurooncol
; 164(3): 711-720, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707754
5.
Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy.
Clin Auton Res
; 32(2): 103-114, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149937
6.
On the Way for Patients with Prostate Cancer to the Best Use of PSMA.
Int J Mol Sci
; 23(5)2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269620
7.
Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use.
Eur J Nucl Med Mol Imaging
; 48(4): 1229-1234, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33006657
8.
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 48(1): 123-133, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385647
9.
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.
Eur J Nucl Med Mol Imaging
; 48(12): 4067-4076, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031719
10.
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
Eur J Nucl Med Mol Imaging
; 48(1): 113-122, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383093
11.
The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
Eur J Nucl Med Mol Imaging
; 47(3): 695-712, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776632
12.
Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
Eur J Nucl Med Mol Imaging
; 47(3): 740, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863137
13.
Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis.
Int J Mol Sci
; 21(23)2020 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260535
14.
Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer.
Eur J Nucl Med Mol Imaging
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740575
15.
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.
Eur J Nucl Med Mol Imaging
; 46(10): 2112-2137, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254038
16.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 46(12): 2536-2544, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440799
17.
Current status of theranostics in prostate cancer.
Eur J Nucl Med Mol Imaging
; 45(3): 471-495, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29282518
18.
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.
Eur J Nucl Med Mol Imaging
; 45(3): 496-508, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247284
19.
Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 45(11): 1873-1883, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766246
20.
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.
Eur J Nucl Med Mol Imaging
; 50(13): 4110-4111, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452871